REDULEN Trademark
Serial Number: 79342473 • Registration: 7185124
REDULEN is a trademark filed by
ESSERRE PHARMA SRL
on April 5, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Larry H. Tronco Holland & Hart, LLP
PO Box 8749
Trademark Docketing
Denver
CO 80201
Trademark Details
Filing Date
April 5, 2022
Registration Date
October 10, 2023
Published for Opposition
July 25, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 13, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 13, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 10, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2023 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 27, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 31, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 30, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 23, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 21, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 16, 2022 REPR
